Innovative Eyewear Inc
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
During the quarter ended September 30, 2026, none of the Company’s directors or officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K.
Sales under Rule 10b5-1 Trading Plans
During the quarter ended September 30, 2026, Harrison Gross, our Chief Executive Officer, sold an aggregate of 13,974 shares pursuant to the terms of a Rule 10b5-1 trading plan that was adopted on December 9, 2025.
During the quarter ended September 30, 2026, Konrad Dabrowski, our Chief AI and Growth Officer, sold an aggregate of 6,935 shares pursuant to the terms of a Rule 10b5-1 trading plan that was adopted on December 9, 2025.
During the quarter ended September 30, 2026, David Eric Cohen, our Chief Technology Officer, sold an aggregate of 9,856 shares pursuant to the terms of a Rule 10b5-1 trading plan that was adopted on December 9, 2025.
During the quarter ended September 30, 2026, Oswald Gayle, our Chief Financial Officer, sold an aggregate of 7,959 shares pursuant to the terms of a Rule 10b5-1 trading plan that was adopted on December 9, 2025.
During the quarter ended September 30, 2026, Joaquin Abondano, our Chief Operating Officer, sold an aggregate of 8,932 shares pursuant to the terms of a Rule 10b5-1 trading plan that was adopted on December 9, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.